Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/176193
Title: | Effectiveness of a pharmacogenetic tool at Improving treatment efficacy in major depressive disorder: A meta-analysis of three clinical studies |
Author: | Vilches, Silvia Tuson, Miquel Vieta i Pascual, Eduard, 1963- Álvarez, Enric Espadaler, Jordi |
Keywords: | Antidepressius Psiquiatria Farmacogenètica Antidepressants Psychiatry Pharmacogenetics |
Issue Date: | 2-Sep-2019 |
Publisher: | MDPI |
Abstract: | Several pharmacogenetic tests to support drug selection in psychiatric patients have recently become available. The current meta-analysis aimed to assess the clinical utility of a commercial pharmacogenetic-based tool for psychiatry (Neuropharmagen®) in the treatment management of depressive patients. Random-effects meta-analysis of clinical studies that had examined the effect of this tool on the improvement of depressive patients was performed. Effects were summarized as standardized differences between treatment groups. A total of 450 eligible subjects from three clinical studies were examined. The random effects model estimated a statistically significant effect size for the pharmacogenetic-guided prescription (d = 0.34, 95% CI = 0.11-0.56, p-value = 0.004), which corresponded to approximately a 1.8-fold increase in the odds of clinical response for pharmacogenetic-guided vs. unguided drug selection. After exclusion of patients with mild depression, the pooled estimated effect size increased to 0.42 (95% CI = 0.19-0.65, p-value = 0.004, n = 287), corresponding to an OR = 2.14 (95% CI = 1.40-3.27). These results support the clinical utility of this pharmacogenetic-based tool in the improvement of health outcomes in patients with depression, especially those with moderate-severe depression. Additional pragmatic RCTs are warranted to consolidate these findings in other patient populations. |
Note: | Reproducció del document publicat a: https://doi.org/10.3390/pharmaceutics11090453 |
It is part of: | Pharmaceutics, 2019, vol. 11, num. 9, p. 453 |
URI: | http://hdl.handle.net/2445/176193 |
Related resource: | https://doi.org/10.3390/pharmaceutics11090453 |
ISSN: | 1999-4923 |
Appears in Collections: | Articles publicats en revistes (Medicina) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
691628.pdf | 1.05 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License